Prevalence of asthma and atopy in sarcoidosis

Respirology

Volumn 17, Issue 2, 2012, Pages 285-290

  Wilsher, Margaret ^a   Hopkins, Raewyn ^a   Zeng, Irene ^a   Cornere, Megan ^a   Douglas, Richard ^b  

^a Respiratory Services   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

allergy; asthma; cytokine; sarcoidosis

Indexed keywords

ANTIASTHMATIC AGENT;

ADULT; AGED; ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; DYSPNEA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; SELF REPORT; WHEEZING;

ADULT; AGED; ASTHMA; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; RISK FACTORS; SARCOIDOSIS; YOUNG ADULT;

EID: 84856276207     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02066.x     Document Type: Article

References (28)

1. Baughman RP, Lower EE, du Bois RM,. Sarcoidosis. Lancet 2003; 361: 1111-18. (Pubitemid 36369566)
2. Pinkston P, Bitterman PB, Crystal RG,. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N. Engl. J. Med. 1983; 308: 793-800. (Pubitemid 13114673)
3. Robinson DS, Hamid Q, Ying S, et al,. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992; 326: 298-304.
4. Romagnani S,. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 1996; 80 (3 Pt 1): 225-35.
5. Shaheen SO, Aaby P, Hall AJ, et al,. Measles and atopy in Guinea-Bissau. Lancet 1996; 347: 1792-6. (Pubitemid 26323329)
6. Shirakawa T, Enomoto T, Shimazu S, et al,. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 77-9. (Pubitemid 27020311)
7. Omenaas E, Jentoft HF, Vollmer WM, et al,. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 2000; 55: 454-8. (Pubitemid 30307260)
8. Crane J, Lewis S, Slater T, et al,. The self reported prevalence of asthma symptoms amongst adult New Zealanders. N. Z. Med. J. 1994; 107: 417-21.
9. D'Souza W, Lewis S, Cheng S, et al,. The prevalence of asthma symptoms, bronchial hyperresponsiveness and atopy in New Zealand adults. N. Z. Med. J. 1999; 112: 198-202.
10. Scadding J, Mitchell D, (eds). Sarcoidosis, 2nd edn. Chapman and Hall, London, 1985.
11. Burney PG, Luczynska C, Chinn S, et al,. The European Community Respiratory Health Survey. Eur. Respir. J. 1994; 7: 954-60. (Pubitemid 24153598)
12. Morell F, Levy G, Orriols R, et al,. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest 2002; 121: 1239-44. (Pubitemid 34280449)
13. Wells AU, Hirani N, British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee, Thoracic Society of Australia, New Zealand Thoracic Society, Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 5): v1-58.
14. Wilsher M, Hopkins R, Young L, et al,. Characteristics of sarcoidosis in Maori and Pacific Islanders. Am. J. Respir. Crit. Care Med. 2005; 171 (4 Suppl.): A864.
15. Pekkanen J, Sunyer J, Anto JM, et al.,. Operational definitions of asthma in studies on its aetiology. Eur. Respir. J. 2005; 26: 28-35. (Pubitemid 40945928)
16. Kokturk N, Han ER, Turktas H, et al,. Atopic status in patients with sarcoidosis. Allergy Asthma Proc. 2005; 26: 121-4. (Pubitemid 40770073)
17. Saeki S, Matsuse H, Mukae H, et al,. [Clinical evaluation of bronchial asthma complicated with sarcoidosis]. Nihon Kokyuki Gakkai Zasshi 2003; 41: 777-80.
18. da Cunha SS, Cruz AA, Dourado I, et al,. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 2004; 59: 857-62. (Pubitemid 39005827)
19. Marks GB, Ng K, Zhou J, et al,. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol. 2003; 111: 541-9. (Pubitemid 36337875)
20. Erb KJ, Holloway JW, Sobeck A, et al,. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 1998; 187: 561-9. (Pubitemid 28093358)
21. Hamid QA, Schotman E, Jacobson MR, et al,. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol. 1997; 99: 254-60. (Pubitemid 27091578)
22. Moller DR, Forman JD, Liu MC, et al,. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 1996; 156: 4952-60. (Pubitemid 26174485)
23. Shigehara K, Shijubo N, Ohmichi M, et al,. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J. Immunol. 2001; 166: 642-9. (Pubitemid 32038488)
24. Hofstra CL, Van Ark I, Hofman G, et al,. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 1998; 161: 5054-60. (Pubitemid 28492088)
25. Yoshimoto T, Okamura H, Tagawa YI, et al,. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl Acad. Sci. U.S.A. 1997; 94: 3948-53. (Pubitemid 27180479)
26. Rook G,. Th1- or Th2-cell commitment during infectious disease: an oversimplification? Trends Immunol. 2001; 22: 481-2. (Pubitemid 32778574)
27. Fehervari Z, Sakaguchi S, Fehervari Z, et al,. CD4+ Tregs and immune control. J. Clin. Invest. 2004; 114: 1209-17.
28. Idali F, Wahlstrom J, Muller-Suur C, et al,. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin. Exp. Immunol. 2008; 152: 127-37. (Pubitemid 351347561)